ConductScience.org, home

Paper37463564

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.

Tamma PD and 5 others. Clin Infect Dis, 2023. Cited by 620 papers, by iCite.

Cite this record

ConductScience Library. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Papers, record 37463564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37463564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
620
iCite
Relative citation ratio, by iCite
111
iCite
Revised in PubMed
2023-07-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tamma PDPranita Dhttps://orcid.org/0000-0002-4143-6324
2Aitken SLSamuel L
3Bonomo RARobert A
4Mathers AJAmy J
5van Duin DDavid
6Clancy CJCornelius J

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07398703Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICUBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by430

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 620 citations.

PMIDTitleJournalYearIn PapersSource
42973857Clinical and microbiological determinants of treatment failure in complicated urinary tract infection: a four-hospital cohort of enterobacterales infections in Misurata, Libya.Front Med (Lausanne)2026https://conductscience.org/library/papers/42973857PubMed
42953638Multidisciplinary Antimicrobial Stewardship Program in an Indian ICU: A Time-Series Analysis of Diagnostic Practices and Antibiotic Use.Cureus2026https://conductscience.org/library/papers/42953638PubMed
42938768Concordance Between Multiplex-PCR Resistance-Gene Detection and MIC-Based Susceptibility in Gram-Negative Clinical Isolates from a Romanian Tertiary Hospital.Antibiotics (Basel)2026https://conductscience.org/library/papers/42938768PubMed
42938103Diagnostic and Management Challenges in Mixed-Source MDR Sepsis in a Kidney Transplant Recipient with an Infected Sacral Pressure Ulcer Treated with VAC Therapy: A Case Report.Diagnostics (Basel)2026https://conductscience.org/library/papers/42938103PubMed
42921315Phenazine Biosynthesis Inhibitors as Pseudomonas aeruginosa Antivirulence Agents.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42921315PubMed
42886673Laboratory-based surveillance of antimicrobial non-susceptibility in Enterobacter species over 12 years at a tertiary-care hospital in Saudi Arabia.PLoS One2026https://conductscience.org/library/papers/42886673PubMed
42825581Genomic characterization of carbapenem-resistant organisms from pediatric patients with hematological malignancies and genomic comparison of infection versus intestinal colonizing strains.Microbiol Spectr2026https://conductscience.org/library/papers/42825581PubMed
42807182
Clinical gradient and predictors for stepwise resistance escalation of carbapenem-susceptible, carbapenem-resistant, and difficult-to-treat resistant Pseudomonas aeruginosa infections: a 6-year retrospective cohort study.
Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42807182PubMed
42803855Risk factors for recurrent urinary tract infection after SGLT2 inhibitor reinitiation in type 2 diabetes.Endocrine2026https://conductscience.org/library/papers/42803855PubMed
42795652Paired In Vitro Susceptibility of Cefiderocol and Colistin in Colistin-Resistant, Extensively Drug-Resistant Gram-Negative Bacilli: A Single-Centre, MIC-Based Analysis of 236 Clinical Isolates.Microorganisms2026https://conductscience.org/library/papers/42795652PubMed
42699590The influence of chlorogenic acid disinfection on the oral microbiota of alginate impressions.J Oral Microbiol2026https://conductscience.org/library/papers/42699590PubMed
42696374Computed tomography-guided precision biopsy combined with metagenomic next-generation sequencing for etiological diagnosis in patients with blood culture-negative systemic infections.J Int Med Res2026https://conductscience.org/library/papers/42696374PubMed
42687566One Model to Dose Them All: A Population Pharmacokinetic Model for Multiple Aminoglycosides Across the Human Lifespan.J Clin Pharmacol2026https://conductscience.org/library/papers/42687566PubMed
42683082Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies.Front Microbiol2026https://conductscience.org/library/papers/42683082PubMed
42668754Multidrug resistant bacterial infection in liver transplant recipients: A Deterrent and obstacle.Pak J Med Sci2026https://conductscience.org/library/papers/42668754PubMed
42657893Clinical use of ampicillin-sulbactam/ceftazidime-avibactam combination therapy for carbapenem-resistant Acinetobacter baumannii complex infections.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42657893PubMed
42654965Genotypic and Phenotypic Resistance Profiles of Invasive Acinetobacter baumannii Isolates at Bulgarian University Hospital.Microorganisms2026https://conductscience.org/library/papers/42654965PubMed
42650721Real-World Antibiotic Strategies for Multidrug-Resistant Pseudomonas aeruginosa: Evidence from the Italian SUSANA Multicentre Study.Antibiotics (Basel)2026https://conductscience.org/library/papers/42650721PubMed
42638875Development and validation of an interpretable machine learning model for predicting multidrug-resistant infections in ICU patients.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42638875PubMed
42636225
Carbapenem resistance and susceptibility to Ceftazidima/avibactam and Ceftolozane/tazobactam in Pseudomonas aeruginosa and Enterobacterales in a reference laboratory in Lima, Peru: A cross-sectional study.
PLoS One2026https://conductscience.org/library/papers/42636225PubMed

See all 430 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37463564

GET https://conductscience.org/api/papers/v1/37463564/cited_by?page=2